Search results for "LIPIDS"

showing 10 items of 2228 documents

Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome

2010

Background: Although dyslipidemia is common in the polycystic ovary syndrome (PCOS), current diagnostic guidelines suggest to evaluate only plasma HDL-cholesterol and triglyceride concentrations, assuming that, in this disorder, cardiovascular risk is mainly due to the presence of the metabolic syndrome (MS). In the US, MS has been found in up to 50% of PCOS, but in other countries its prevalence is lower. Methods: We compared the prevalence of MS with that of increased LDL- and non-HDL-cholesterol levels in 350 Mediterranean PCOS women (244 anovulatory and 106 ovulatory), and 95 normo-weight and 90 body mass index (BMI)-matched controls. Results: The prevalence of MS was 7.1% in PCOS, high…

AdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesEndocrinology Diabetes and MetabolismYoung Adultchemistry.chemical_compoundEndocrinologyRisk FactorsInternal medicinemedicineHumansIncreased ldlTriglyceridesMetabolic SyndromeTriglyceridebusiness.industryCholesterol HDLnutritional and metabolic diseasesCholesterol LDLPrognosismedicine.diseaseLipidsPolycystic ovaryCholesterolEndocrinologychemistryCardiovascular DiseasesCase-Control StudiesFemalelipids (amino acids peptides and proteins)Metabolic syndromebusinessBody mass indexBiomarkersDyslipidemiaFollow-Up StudiesPolycystic Ovary SyndromeJournal of Endocrinological Investigation
researchProduct

Contrast-enhanced ultrasonography: usefulness in the assessment of postoperative recurrence of Crohn's disease.

2013

Abstract Aim The aim of this study was to assess whether the contrast-enhanced ultrasonography (CEUS) can increase the value of the ultrasonography in the study of postoperative recurrence of Crohn's disease (CD). Materials and methods 60 patients with CD who had previously undergone ileocolic resection underwent prospectively both CEUS and colonoscopy within a 3-day period. The sonographic examination included evaluation of bowel wall thickness, transmural complications, colour Doppler grade and contrast-enhanced US. In addition a sonographic score was established. The capacity of CEUS to diagnose endoscopic recurrence, as well as its severity, was assessed by calculating the sensitivity, …

AdultMalemedicine.medical_specialtyAdolescentmedicine.medical_treatmentFistulaSulfur HexafluorideColonoscopyContrast MediaDoppler echocardiographySensitivity and SpecificitySeverity of Illness IndexYoung AdultCrohn DiseaseIleumRecurrencePositive predicative valuemedicineHumansProspective StudiesUltrasonography Doppler ColorColectomyPhospholipidsColectomyReceiver operating characteristicmedicine.diagnostic_testbusiness.industryGastroenterologyGeneral MedicineColonoscopyMiddle Agedmedicine.diseaseEndoscopyTreatment OutcomeFemaleRadiologybusinessContrast-enhanced ultrasoundFollow-Up StudiesJournal of Crohn'scolitis
researchProduct

Effects of the association of aging and obesity on lipids, lipoproteins and oxidative stress biomarkers: a comparison of older with young men.

2011

In this study, plasma lipids, lipoproteins and markers of oxidant/antioxidant status were investigated in young (n = 45) and older (n = 40) obese men and compared to those in young (n = 65) and older (n = 55) normal weight controls. The purpose was to determine whether obesity exacerbates or not lipid, lipoprotein abnormalities and oxidative stress in older men. Our findings showed that all obese patients had increased plasma triglyceride, cholesterol, LDL-cholesterol, -triglyceride and HDL-triglyceride levels concentrations compared to controls (P < 0.01). However, the younger obese men had relatively larger and accentuated changes in plasma lipids and lipoproteins than the older patients.…

AdultMalemedicine.medical_specialtyAgingLipid PeroxidesAntioxidantEndocrinology Diabetes and Metabolismmedicine.medical_treatmentLipoproteinsMedicine (miscellaneous)medicine.disease_causeAntioxidantsBody Mass IndexProtein Carbonylationchemistry.chemical_compoundInternal medicineMedicineHumansObesityAgedchemistry.chemical_classificationNutrition and DieteticsTriglyceridebusiness.industryCholesterolSuperoxide DismutaseGlutathione peroxidaseMiddle Agedmedicine.diseaseObesityLipidsOxidative StressEndocrinologychemistrylipids (amino acids peptides and proteins)Cardiology and Cardiovascular MedicinebusinessBody mass indexOxidative stressBiomarkersLipoproteinNutrition, metabolism, and cardiovascular diseases : NMCD
researchProduct

Enhanced oxidative susceptibility and reduced antioxidant content of metabolic precursors of small, dense low-density lipoproteins.

2001

Abstract PURPOSE: Elevated plasma concentrations of low-density lipoproteins (LDL) increase risk for coronary heart disease. However, lipoprotein profiles rich in small, dense LDL particles confer greater risk than those that mainly consist of large, buoyant LDL. This may be due, in part, to the greater oxidative susceptibility of small, dense LDL. In the current studies, we tested whether differences in the oxidative behavior of buoyant and dense LDL arise from differences in their immediate metabolic precursors, intermediate-density lipoproteins. SUBJECTS AND METHODS: We compared the properties of intermediate-density lipoproteins and buoyant and dense LDL subfractions in 9 subjects with …

AdultMalemedicine.medical_specialtyAntioxidantParinaric Acidmedicine.medical_treatmentOxidative phosphorylationAntioxidantsReference ValuesInternal medicineMedicineHumansPolyacrylamide gel electrophoresisFluorescent DyesIntermediate-density lipoproteinbusiness.industryGeneral MedicineLipoproteins LDLEndocrinologyPhenotypeFatty Acids Unsaturatedlipids (amino acids peptides and proteins)Electrophoresis Polyacrylamide GelFemaleUltracentrifugebusinessQuantitative analysis (chemistry)Oxidation-ReductionLipoproteinThe American journal of medicine
researchProduct

Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population.

2000

Genetic variants at the cholesteryl ester transfer protein (CETP) locus have been associated with CETP activity and mass, as well as plasma high density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I levels. We have examined allele frequencies and lipid associations for the common CETP TaqIB polymorphism in a sample of 514 healthy subjects (231 men, mean age 37.4 years, and 283 women, mean age 35.7 years) residing in Valencia (Spain). The frequency of the less common TaqIB2 allele (0.351; 95% CI: 0.322-0. 380) was significantly lower than those reported for Northern European populations. Consistent with previous studies, we found a significant association of the TaqIB polymorphism w…

AdultMalemedicine.medical_specialtyApolipoprotein BAdolescentAlcohol DrinkingGenotypeCoronary DiseaseBody Mass Indexchemistry.chemical_compoundHigh-density lipoproteinGene FrequencyInternal medicineGenotypeCholesterylester transfer proteinmedicineHumansTaq PolymeraseAlleleAllele frequencyAllelesAgedGlycoproteinsGeneticsbiologyCholesterolCholesterol HDLSmokingGenetic VariationMiddle AgedLipidsCholesterol Ester Transfer ProteinsEndocrinologyApolipoproteinsCross-Sectional StudieschemistrySpainMultivariate Analysisbiology.proteinlipids (amino acids peptides and proteins)FemaleCardiology and Cardiovascular MedicineCarrier ProteinsBody mass indexAtherosclerosis
researchProduct

Small and dense LDL in Familial Combined Hyperlipidemia and N291S polymorphism of the lipoprotein lipase gene

2009

18 pagesm 2 figures. -- PMID: 19335919 [PubMed]

AdultMalemedicine.medical_specialtyApolipoprotein BAdolescentEndocrinology Diabetes and MetabolismPopulationClinical BiochemistryHyperlipidemia Familial CombinedMutation MissenseBlood lipidschemistry.chemical_compoundYoung AdultHigh-density lipoproteinEndocrinologyInternal medicinePrevalenceMedicineShort PaperHumanseducationlcsh:RC620-627AgedBiochemistry medicalLipoprotein lipaseeducation.field_of_studyPolymorphism Geneticmedicine.diagnostic_testbiologyCholesterolbusiness.industryBiochemistry (medical)Cholesterol LDLMiddle AgedAtherosclerosisLipidslcsh:Nutritional diseases. Deficiency diseasesLipoprotein LipaseEndocrinologychemistrySpainLow-density lipoproteinCase-Control Studiesbiology.proteinFemalelipids (amino acids peptides and proteins)businessLipid profile
researchProduct

Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic dono…

1998

Plasma of patients with Tangier disease (TD) is devoid of alpha-LpA-I (apolipoprotein A-I-containing lipoprotein), which in normolipidemic plasma constitutes the majority of high density lipoprotein (HDL). The residual amounts of apolipoprotein A-I (apo A-I) in TD plasma have electrophoretic prebeta1-LpA-I mobility. We have previously demonstrated that TD plasma does not convert prebeta1-LpA-I into alpha-LpA-I. In this study we found that plasmas of normolipidemic controls, apo A-I-deficient patients and patients with fish-eye disease, but not plasmas of six TD patients, convert biotinylated lipid-free apo A-I into alpha-LpA-I. Supplementation of plasma with free oleic acid or fatty acid fr…

AdultMalemedicine.medical_specialtyApolipoprotein BLipoproteinsBlood Donorschemistry.chemical_compoundTangier diseaseHigh-density lipoproteinReference ValuesPhospholipid transfer proteinInternal medicinemedicineHumansPhospholipidsTangier DiseaseAgedApolipoprotein A-IbiologyChemistryCholesterolVesicleAlbuminMiddle Agedmedicine.diseaseEndocrinologybiology.proteinFemalelipids (amino acids peptides and proteins)Lipoproteins HDLCardiology and Cardiovascular MedicineLipoproteinAtherosclerosis
researchProduct

High Plasma Phospholipid Transfer Protein Levels as a Risk Factor for Coronary Artery Disease

2003

Objective— Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. PLTP-deficient mice have demonstrated increased antioxidation potential as well as a decrease in apolipoprotein B secretion and atherosclerotic lesions. In humans, high PLTP is associated with type II diabetes and obesity. Methods and Results— To assess the relationship between PLTP activity and coronary artery disease (CAD), a novel, high-throughput method to measure plasma PLTP activity was used, relating it to CAD in 1102 cases and 444 controls. This demo…

AdultMalemedicine.medical_specialtyApolipoprotein BLipoproteinsMyocardial InfarctionCoronary Artery DiseaseAngina PectorisAnginaCoronary artery diseaseReference ValuesRisk FactorsPhospholipid transfer proteinInternal medicinemedicineHumansAngina UnstablePhospholipid Transfer ProteinsRisk factorPhospholipidsAgedbiologybusiness.industryCase-control studyMembrane ProteinsBiological activityMiddle Agedmedicine.diseaseLogistic ModelsEndocrinologyCase-Control Studiesbiology.proteinFemaleAnimal studiesCarrier ProteinsCardiology and Cardiovascular MedicinebusinessArteriosclerosis, Thrombosis, and Vascular Biology
researchProduct

Inability of HDL from abdominally obese subjects to counteract the inhibitory effect of oxidized LDL on vasorelaxation.

2007

Abdominal obesity is associated with a decreased plasma concentration of HDL cholesterol and with qualitative modifications of HDL, such as triglyceride enrichment. Our aim was to determine, in isolated aorta rings, whether HDL from obese subjects can counteract the inhibitory effect of oxidized low density lipoprotein (OxLDL) on endothelium-dependent vasodilation as efficiently as HDL from normolipidemic, lean subjects. Plasma triglycerides were 74% higher (P < 0.005) in obese subjects compared with controls, and apolipoprotein A-I (apoA-I) and HDL cholesterol concentrations were 12% and 17% lower (P < 0.05), respectively. HDL from control subjects significantly reduced the inhibitory effe…

AdultMalemedicine.medical_specialtyApolipoprotein BVasodilator Agentsapolipoprotein A-IVasodilationQD415-436In Vitro TechniquesBiochemistrychemistry.chemical_compoundEndocrinologyHigh-density lipoproteinInternal medicinemedicineAnimalsHumansObesityInhibitory effectAbdominal obesityAortaTriglyceridesbiologyTriglycerideCholesterolCholesterol HDLnutritional and metabolic diseasesCell BiologyMiddle Agedmedicine.diseaseObesityAcetylcholineLipoproteins LDLVasodilationEndocrinologychemistryhigh density lipoproteinbiology.proteinoxidized low density lipoproteinlipids (amino acids peptides and proteins)FemaleCholesterol EstersRabbitsmedicine.symptomJournal of lipid research
researchProduct

Sulfatide excreting heterozygous carrier of juvenile metachromatic leukodystrophy or asymptomatic patient of adult metachromatic leukodystrophy.

1975

In a family with juvenile metachromatic leukodystrophy (sulfatide lipidosis) 2 patients showed residual arysulfatase A activities of 5--6%. The patients' healthy father was characterized biochemically by a 39% normal activity of leukocyte plus plasma arylsulfatase A. The father was further characterized by a high sulfatide excretion (0.2--0.5 mg/I urine) and, paradoxically, by a normal sulfatide degrading enzyme activity in vitro. This special carrier is suspected to be heterozygous for a) arylsulfatase A deficiency and b) arylsulfatase A (sulfatidase) lability. This presumed additional genetic defect could be the cause of the sulfatide excretion which, in turn, would be a sign of the precl…

AdultMalemedicine.medical_specialtyArylsulfatase AHeterozygoteUrineBiologyAsymptomaticExcretionDrug StabilityInternal medicineGeneticsmedicineHumansChildGenetics (clinical)ArylsulfatasesSulfoglycosphingolipidsLeukodystrophy Metachromaticmedicine.diseaseEnzyme assayIn vitroMetachromatic leukodystrophyEnzyme ActivationEndocrinologybiology.proteinFemalemedicine.symptomSulfatasesArylsulfataseHumangenetik
researchProduct